FDA staff reviewing Musk’s Neuralink were included in DOGE employee firings, sources say
- About 20 employees from the FDA's office of Neurological and Physical Medicine Devices were fired, including some involved with Neuralink, as reported by two sources.
- The layoffs raised concerns about the FDA's ability to safely process medical device applications, according to external experts and sources familiar with the matter.
- Concerns were expressed that the layoffs could be intimidating for the FDA professionals overseeing Neuralink's trial, raising worries about trial safety.
- Neuralink is testing its device that enables paralyzed individuals to control digital devices with their thoughts, having received FDA approval for its first human clinical trial in May 2023.
27 Articles
27 Articles
Musk’s DOGE Operatives Should Leave the FDA Alone
The recent firings of certain FDA staff working on the review of a medical device made by Elon Musk’s neurotechnology company, Neuralink, presents a glaring conflict of interest for Musk and his operatives at the so-called Department of Government Efficiency (DOGE).Among the many employees at the FDA Center for Devices and Radiological Health terminated were staff reviewing the implantable brain computer interface developed by Neuralink, accordi…
FDA employees who were reviewing clinical trials for Elon Musk’s Neuralink have been fired
In a recent development, approximately 20 employees from the U.S. Food and Drug Administration (FDA) were dismissed over the weekend as part of a broader federal workforce reduction led by the Department of Government Efficiency (DOGE). Notably, several of these individuals were involved in reviewing clinical trial applications for Elon Musk’s brain implant company, Neuralink. […]
Elon Musk faces more conflict-of-interest questions after DOGE fires FDA staff reviewing Neuralink
Since the moment the Department of Government Efficiency (DOGE) was first proposed, Elon Musk’s critics have warned that the world’s richest man was at risk of making decisions that could be a conflict of interest, given his multiple business operations. With recent cuts at the Food and Drug Administration (FDA), those fears are increasing. Roughly 20 employees of the FDA’s office of neurological and physical medicine devices were let go over th…
Coverage Details
Bias Distribution
- 55% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage